Cargando…

Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro

The initiation of cell-mediated immunity to Epstein-Barr virus (EBV) has been analyzed with cells from EBV-seronegative blood donors in culture. The addition of dendritic cells (DCs) is essential to prime naive T cells that recognize EBV-latent antigens in enzyme-linked immunospot assays for interfe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bickham, Kara, Goodman, Kiera, Paludan, Casper, Nikiforow, Sarah, Tsang, Ming Li, Steinman, Ralph M., Münz, Christian
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2003
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194129/ https://www.ncbi.nlm.nih.gov/pubmed/14657218 http://dx.doi.org/10.1084/jem.20030646

Ejemplares similares

Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8(+) Killer T Cells
por: Subklewe, Marion, et al.
Publicado: (2001)

Human Cd4(+) T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
por: Münz, Christian, et al.
Publicado: (2000)

Dendritic cells during Epstein Barr virus infection
por: Christian, Münz
Publicado: (2014)

Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
por: Münz, Christian
Publicado: (2017)

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity
por: Münz, Christian, et al.
Publicado: (2005)

Cytolytic T lymphocytes from HLA-B8(+ )donors frequently recognize the Hodgkin's lymphoma associated latent membrane protein 2 of Epstein Barr virus
por: Tsang, Ming L, et al.
Publicado: (2011)

Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)

Immune Escape by Non-coding RNAs of the Epstein Barr Virus
por: Münz, Christian
Publicado: (2021)

Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10
Publicado: (1993)

Redirecting T Cells against Epstein–Barr Virus Infection and Associated Oncogenesis
por: Münz, Christian
Publicado: (2020)

Immune Control and Vaccination against the Epstein–Barr Virus in Humanized Mice
por: Münz, Christian
Publicado: (2019)

Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines
Publicado: (1994)

Immortalization of human lymphocytes by Epstein-Barr virus.
por: Miller, G.
Publicado: (1982)

Tonsilar NK Cells Restrict B Cell Transformation by the Epstein-Barr Virus via IFN-γ
por: Strowig, Till, et al.
Publicado: (2008)

Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection
por: Münz, Christian
Publicado: (2021)

Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis
Publicado: (1978)

NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016)

Co-Infection of the Epstein–Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus
por: Böni, Michelle, et al.
Publicado: (2022)

Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma
por: Lee, Jae Myun, et al.
Publicado: (2011)

Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk
por: Läderach, Fabienne, et al.
Publicado: (2021)

Altered Immune Response to the Epstein–Barr Virus as a Prerequisite for Multiple Sclerosis
por: Läderach, Fabienne, et al.
Publicado: (2022)

Epstein–Barr Virus: Diseases Linked to Infection and Transformation
por: Jha, Hem C., et al.
Publicado: (2016)

Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
por: Baccianti, Francesco, et al.
Publicado: (2023)

Epstein-Barr Virus Nuclear Antigen 1: from Immunologically Invisible to a Promising T Cell Target
por: Münz, Christian
Publicado: (2004)

Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein–Barr Virus
por: Deng, Yun, et al.
Publicado: (2021)

Characteristics of Epstein-Barr virus activation of human B lymphocytes
Publicado: (1981)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

STAT3 imparts BRCAness by impairing homologous recombination repair in Epstein-Barr virus-transformed B lymphocytes
por: McIntosh, Michael T., et al.
Publicado: (2020)

Monoclonal antibodies from Epstein-Barr virus-transformed lymphocytes of common marmosets (Callithrix jacchus) immune to malaria
por: Johnston, D.A., et al.
Publicado: (1990)

Epstein-Barr virus transformation of human pre-B cells
Publicado: (1983)

Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
por: Ferlazzo, Guido, et al.
Publicado: (2002)

The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015)

Dual Functions of Interferon Regulatory Factors 7C in Epstein-Barr Virus–Mediated Transformation of Human B Lymphocytes
por: Zhao, Yong, et al.
Publicado: (2010)

Epstein-Barr virus susceptibility of normal human B lymphocyte populations
Publicado: (1984)

Plasticity of DNA Replication Initiation in Epstein-Barr Virus Episomes
por: Norio, Paolo, et al.
Publicado: (2004)

Molecular signature of Epstein-Barr virus infection in MS brain lesions
por: Moreno, Monica A., et al.
Publicado: (2018)

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
por: Hui-Yuen, Joyce, et al.
Publicado: (2011)

Epstein–Barr Virus B Cell Growth Transformation: The Nuclear Events
por: Zhao, Bo
Publicado: (2023)

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
por: Bar-Or, Amit, et al.
Publicado: (2020)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vjg5arm9qnfv9bugjugoqnlbb1